USE OF COMPOSITION INCLUDING AT LEAST ONE HYDROXYMETHYLGLUTARYL-COENZYME A (HMG-COA) REDUCTASE INHIBITOR AND AT LEAST ONE FARNESYL-PYROPHOSPHATE SYNTHASE INHIBITOR

摘要

PROBLEM TO BE SOLVED: To provide a method for using a very useful composition, for example, in the treatment of side effects caused by certain anti-HIV treatments and premature aging and lipodystrophy, which can be caused by protease inhibitors or reverse transcriptase inhibitors.SOLUTION: The composition including at least one hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, at least one farnesyl-pyrophosphate synthase inhibitor, or one of their physiologically acceptable salts is orally administered.